2. Signaling Pathways
  3. Amino Acid Decarboxylase
  4. Amino Acid Decarboxylase Inhibitor

Amino Acid Decarboxylase Inhibitor

Amino Acid Decarboxylase Inhibitors (5):

Cat. No. Product Name Effect Purity
  • HY-W016814
    (Z)-Aconitic acid
    		Inhibitor 99.28%
    (Z)-Aconitic acid is an orally active glutamate decarboxylase inhibitor. (Z)-Aconitic acid reduces IκB-α phosphorylation. (Z)-Aconitic acid inhibits Antigen-induced arthritis and Monosodium urate (HY-B2130A)-induced gout.
  • HY-W016349
    Chelidamic acid
    		Inhibitor 99.93%
    Chelidamic acid is a heterocyclic organic acid with a pyran skeleton. Chelidamic acid has good coordination ability with noble metal ions. Chelidamic acid is also one of the most potent inhibitors of glutamate decarboxylase, with a Ki of 33 μM.
  • HY-103391
    Qc1
    		Inhibitor 98.42%
    Qc1 is a reversible and noncompetitive threonine dehydrogenase (TDH) inhibitor. Qc1 can be used for the research of Metabolic disease.
  • HY-115822
    α-Fluoromethylhistidine dihydrochloride
    		Inhibitor ≥99.0%
    α-Fluoromethylhistidine dihydrochloride is a potent irreversible inhibitor of histidine decarboxylase (HDC) and glutathione S-transferase, demonstrating significant potential in studying histidine metabolism and drug metabolism processes. α-Fluoromethylhistidine dihydrochloride offers an effective approach to inhibit enzymes involved in these metabolic pathways. α-Fluoromethylhistidine dihydrochloride has implications for drug development by revealing off-target effects that may influence physiological drug metabolism and elimination mechanisms.
  • HY-U00065
    Tritoqualine
    		Inhibitor
    Tritoqualine is a histidine decarboxylase inhibitor, that inhibits the release of histidine.